Inspire

 
 
Products

AZASITE®

AZASITE (azithromycin ophthalmic solution) 1% is indicated for the treatment of bacterial conjunctivitis caused by the following organisms: CDC coryneform group G,* Staphylococcus aureus, Streptococcus mitis group, Streptococcus pneumoniae, and Haemophilus influenzae.

Important Safety Information: AZASITE should not be injected subconjunctivally or introduced directly into the anterior chamber of the eye or otherwise administered systemically. In clinical trials, the most common ocular adverse event was eye irritation, which occurred in 1% to 2% of patients.

Please see full Prescribing Information for AZASITE.

*Efficacy for this organism was studied in fewer than 10 infections.


ELESTAT®

ELESTAT (epinastine HCl ophthalmic solution) 0.05% is indicated for the prevention of ocular itching associated with allergic conjunctivitis.

Important Safety Information: ELESTAT ophthalmic solution is contraindicated in those patients who have shown hypersensitivity to epinastine or to any of the other ingredients.

Patients should be advised not to wear a contact lens if their eye is red. ELESTAT ophthalmic solution should not be used to treat contact lens related irritation. The preservative in ELESTAT, benzalkonium chloride, may be absorbed by soft contact lenses. Contact lenses should be removed prior to instillation of ELESTAT ophthalmic solution and may be reinserted after 10 minutes following its administration. The most frequently reported ocular adverse events occurring in approximately 1% to 10% of patients were burning sensation in the eye, folliculosis, hyperemia, and pruritus.

The most frequently reported nonocular adverse events were infection (cold symptoms and upper respiratory infections), seen in approximately 10% of patients, and headache, rhinitis, sinusitis, increased cough, and pharyngitis seen in approximately 1% to 3% of patients. Some of these events were similar to the underlying disease being studied.

Please see full Prescribing Information for ELESTAT.


Inspire licensed AZASITE from InSite Vision Incorporated. AZASITE is a registered trademark owned by InSite. ELESTAT is co-promoted under agreement with Allergan, Inc. ELESTAT is a registered trademark owned by Allergan.